ACB
Aurora Cannabis, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.96
−0.75%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$4.00
From 52W high−28.90%
Volume598764.00
Market cap$250.71M
P/E (TTM)—
P/S (TTM)1.2x
Div yield—
Key dataOct 19, 2026
Open
$4.00
From 52W high
−28.90%
Volume
598764.00
Market cap
$250.71M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.4x
P/E (TTM)
—
RSI (14)
46.2
MomentumView details →
1D Return
−0.75%
YTD Return
−4.98%
SummaryUpdated Jun 1, 2026
Aurora Cannabis Inc. (NASDAQ:ACB) is a Canadian cannabis company founded in 2006 and publicly traded since 2014. Originally established as a medical cannabis producer, Aurora has evolved into one of the world's largest cannabis companies with operations spanning cultivation, production, and distribution across multiple international markets. The company is headquartered in Edmonton, Alberta, and has undergone significant strategic transformation over the past few years, pivoting from a growth-at-all-costs model to a focused, profitability-driven approach centered on high-margin medical cannabis markets globally.
Similar companies
Latest newsMore news →
AURORA CANNABIS INC is evaluating strategic alternatives in response to Curaleaf Holdings, Inc.'s hostile takeover bid, including a potential third-party transaction or remaining independent, to maximize shareholder value.3d agoCuraleaf Holdings, Inc. made a revised bid for AURORA CANNABIS INC.5d agoAURORA CANNABIS INC completed a major expansion of its EU-GMP manufacturing facility in Germany, more than doubling expected annual flower output.12d ago